Project measures / variables set:   CSNA03   dist_f30_cocaine_do

ID, description, units MPD:90333   dist_f30_cocaine_do   distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO   [cm]  
cocaine study
Measures
• day:    • 1    • 2    • 3    • 5    • 7    • 9    • 11    • 12    • 19
Data set, strains CSNA03   DO population w/par   9 strains     sex: both     age: 8-21wks
Procedure open field test
Comparisontimecourse, same cohort
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options
Advanced Plot Options
Separate Plot Factor(s)
Legend Factor(s)
X-Axis Factor(s)
Include/Exclude Factor Values

CSNA03 - distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO


  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary          "within" = Within error     "between" = Between Error (Animal ID)

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
within   day 8 754549236.7208 94318654.5901 30.3343 < 0.0001
within   day:sex 8 60176027.8506 7522003.4813 2.4192 0.0133
within   day:strain 64 816841481.2668 12763148.1448 4.1048 < 0.0001
within   day:sex:strain 64 506132807.4657 7908325.1167 2.5434 < 0.0001
within   Residuals 2856 8880170848.3861 3109303.5183
between   sex 1 461217582.8915 461217582.8915 6.4391 0.0116
between   strain 8 17410907326.2453 2176363415.7807 30.3845 < 0.0001
between   sex:strain 8 731173220.8317 91396652.604 1.276 0.2547
between   Residuals 357 25571014023.5877 71627490.2622

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested		SexAge
CSNA03 90333 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO   [cm]   day 1  dist_f30_cocaine_do_d1 DO population w/par 9 both 8-21wks
CSNA03 90339 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO   [cm]   day 2  dist_f30_cocaine_do_d2 DO population w/par 9 both 8-21wks
CSNA03 90345 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO   [cm]   day 3  dist_f30_cocaine_do_d3 DO population w/par 9 both 8-21wks
CSNA03 90351 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO   [cm]   day 5  dist_f30_cocaine_do_d5 DO population w/par 9 both 8-21wks
CSNA03 90357 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO   [cm]   day 7  dist_f30_cocaine_do_d7 DO population w/par 9 both 8-21wks
CSNA03 90363 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO   [cm]   day 9  dist_f30_cocaine_do_d9 DO population w/par 9 both 8-21wks
CSNA03 90369 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO   [cm]   day 11  dist_f30_cocaine_do_d11 DO population w/par 9 both 8-21wks
CSNA03 90375 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO   [cm]   day 12  dist_f30_cocaine_do_d12 DO population w/par 9 both 8-21wks
CSNA03 90381 open field test cocaine distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO   [cm]   day 19  dist_f30_cocaine_do_d19 DO population w/par 9 both 8-21wks



  •   Or, add these measures to your collection.
       
  •     no folder
  •     put them in new folder